SkyePharma of the UK is to acquire a pharmaceutical manufacturing facility near Lyon, France from Wyeth-Ayerst, a subsidiary of American Home Products. The deal will be made through SkyePharma's principal operating subsidiary Jago.
Under the terms of the agreement, Jago will acquire a newly-incorporated subsidiary of Wyeth into which a 66,000 square meter site at L'Isle D'Abeau, outside Lyon, will have been transferred for a consideration of 1 French franc, according to SkyePharma.
The site comprises a plant and laboratories providing 17,000 square meters of floor space together with an adjoining administration building covering 2,400 square meters.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze